TAK ALG-25 (Nesina 25 mg)
Generic Name: alogliptin
Pill with imprint TAK ALG-25 is Red, Elliptical/Oval and has been identified as Nesina 25 mg. It is supplied by Takeda Pharmaceuticals America, Inc.
Nesina is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Nesina 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TAK ALG-25
Nesina
- Generic Name
- alogliptin
- Imprint
- TAK ALG-25
- Strength
- 25 mg
- Color
- Red
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Dipeptidyl peptidase 4 inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Takeda Pharmaceuticals America, Inc.
- Inactive Ingredients
-
mannitol,
microcrystalline cellulose,
croscarmellose sodium,
magnesium stearate,
hypromellose 2910 (6 mPa.s),
titanium dioxide,
ferric oxide red,
polyethylene glycol 8000,
shellac,
ferrosoferric oxide,
butyl alcohol,
alcohol
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 64764-0250 | Takeda Pharmaceutical Company Limited |
| 45802-0150 | Perrigo Company |
Related images for "TAK ALG-25"
More about Nesina (alogliptin)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (4)
- Drug images
- Pricing & coupons
- En español
- Drug class: dipeptidyl peptidase 4 inhibitors
- FDA approval history
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.